TAZEMETOSTAT HYDROBROMIDE for Epithelioid sarcoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 46 adverse event reports in the FDA FAERS database where TAZEMETOSTAT HYDROBROMIDE was used for Epithelioid sarcoma.
Most Reported Side Effects for TAZEMETOSTAT HYDROBROMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 298 | 22.5% | 60 | 48 |
| Fatigue | 292 | 22.1% | 10 | 41 |
| Disease progression | 267 | 20.2% | 44 | 44 |
| Nausea | 207 | 15.7% | 12 | 31 |
| Product dose omission issue | 183 | 13.8% | 4 | 32 |
| Death | 106 | 8.0% | 105 | 27 |
| Diarrhoea | 100 | 7.6% | 2 | 11 |
| Decreased appetite | 81 | 6.1% | 4 | 17 |
| Asthenia | 75 | 5.7% | 5 | 29 |
| Vomiting | 75 | 5.7% | 8 | 16 |
| Constipation | 66 | 5.0% | 2 | 5 |
| Covid-19 | 65 | 4.9% | 4 | 30 |
| Alopecia | 61 | 4.6% | 2 | 8 |
| Headache | 61 | 4.6% | 3 | 5 |
| Pain | 58 | 4.4% | 5 | 17 |
Other Indications for TAZEMETOSTAT HYDROBROMIDE
Follicular lymphoma (439)
Soft tissue sarcoma (298)
Off label use (102)
B-cell lymphoma (91)
Malignant connective tissue neoplasm (72)
Product used for unknown indication (54)
Follicular lymphoma stage ii (38)
Follicular lymphoma stage i (34)
Brain neoplasm malignant (31)
Neoplasm malignant (23)
Other Drugs Used for Epithelioid sarcoma
DOXORUBICIN (16)
IFOSFAMIDE (12)
NIVOLUMAB (9)
PAZOPANIB (9)
VINCRISTINE (9)
IPILIMUMAB (7)
CYCLOPHOSPHAMIDE (6)
DACTINOMYCIN (5)
DOCETAXEL (5)
ERIBULIN (5)